LDL-C Goal Attainment According to Prescribed Lipid-Lowering Therapy: Results from the LIPIDE European Survey

Aug-09

AUTHORS : Dr Eric Van Ganse (Details for study: Hopital Pierre Wertheimer, Bron), Lyon Pharmaco-Epidemiology Unit- UMR 5558 CNRS-Claude Bernard Lyon 1 University, Lyon, France – Email: eric.van-ganse@univ-lyon1.fr

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 18(S1):154

DOI : 10.1002/pds.1806

LDL-C Goal Attainment According to Prescribed Lipid-Lowering Therapy: Results from the LIPIDE European Survey

More publications

Association Between Type 2 Diabetes Onset Age and Risk of Cardiovascular Disease and Mortality: Two Cohort Studies from United Kingdom and Hong Kong

Characteristics of Patients With Atherosclerotic Cardiovascular Disease in Belgium and Current Treatment Patterns for the Management of Elevated LDL-C Levels

Unveiling unique clinical phenotypes of hip fracture patients and the temporal association with cardiovascular events